FDA recall D-0003-2022

Azurity Pharmaceuticals, Inc. · Class I · drug

Product

Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.7 g Vancomycin Hydrochloride USP, powder for oral solution and 1 bottle containing 145 mL Grape Flavored Diluent for reconstitution per carton, Rx only, Manufactured for: Azurity pharmaceuticals, Wilmington, MA 01887, NDC 65628-206-05.

Reason for recall

Product Mix-up: Incorrect diluent component included in the kit.

Distribution

USA nationwide

Key facts

Status
Terminated
Initiation date
2021-08-24
Report date
2021-10-13
Termination date
2022-05-12
Voluntary/Mandated
Voluntary: Firm initiated
Location
Wilmington, MA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0003-2022